VCAM1 and cancer: Liposomes carrying antitumor drugs (emtansine or doxorubicin) were hybridized with macrophage or NK cell vesicles for targeted cancer therapy through interactions of α4β1/VCAM-1 and NKG2-D and its ligands, respectively.